Toggle light / dark theme

Biotechnology meets fashion and sports performance: Trends in the apparel industry

Spiders, mushrooms and algae may help build the next Hilfiger, Levi and Chanel.

Organisms are the great designers of our planet, producing materials in distinct patterns to serve a specific function. Bees produce hexagonal honeycombs to store honey, spiders weave symmetrical webs to capture prey, and nautiluses form a logarithmic spiral shell to protect their insides. Synthetic biologists, ever inspired by nature, are leveraging these unique abilities, harnessing nature’s potential to revolutionize apparel by guiding structural assemblies at the molecular level.

Here are three examples of innovative companies — in Tokyo, New York, and Berkeley — that are letting nature show the way to better, more sustainable materials in a quest to alter the fashion and apparel industries forever.

Adult hippocampal neurogenesis is abundant in neurologically healthy subjects and drops sharply in patients with Alzheimer’s disease

https://paper.li/e-1437691924#/ https://www.nature.com/articles/s41591-019-0375-9


The hippocampus is one of the most affected areas in Alzheimer’s disease (AD). Moreover, this structure hosts one of the most unique phenomena of the adult mammalian brain, namely, the addition of new neurons throughout life. This process, called adult hippocampal neurogenesis (AHN), confers an unparalleled degree of plasticity to the entire hippocampal circuitry3,4. Nonetheless, direct evidence of AHN in humans has remained elusive. Thus, determining whether new neurons are continuously incorporated into the human dentate gyrus (DG) during physiological and pathological aging is a crucial question with outstanding therapeutic potential. By combining human brain samples obtained under tightly controlled conditions and state-of-the-art tissue processing methods, we identified thousands of immature neurons in the DG of neurologically healthy human subjects up to the ninth decade of life. These neurons exhibited variable degrees of maturation along differentiation stages of AHN. In sharp contrast, the number and maturation of these neurons progressively declined as AD advanced. These results demonstrate the persistence of AHN during both physiological and pathological aging in humans and provide evidence for impaired neurogenesis as a potentially relevant mechanism underlying memory deficits in AD that might be amenable to novel therapeutic strategies.

Gene-Editing Record Smashed With Over 13,000 Changes Made to a Single Human Cell

Using a modified version of CRISPR, a team of geneticists has successfully triggered 13,200 genetic changes to a single human cell. That’s a new record, by a long shot. This sweeping new editing process could eventually be used to strip DNA of useless or dangerous genetic information—or create entirely new kinds of life.

New research uploaded to the preprint bioRxiv server describes the achievement, in which a Harvard University team led by George Church edited the living crap out of a single human cell to the tune of 13,200 total modifications. Incredibly, the cell survived. The previous record for bulk edits made to a single cell was set in 2017, when Church and his colleagues knocked out 62 copies of a retrovirus found in pig genomes. The new achievement is thus “three orders of magnitude greater” than the previous standard, the authors wrote in their paper.

Chronic Inflammation Leads to Toxic NET Buildup

A new review discusses how neutrophils release toxic substances into the body under inflammatory conditions, detailing one of the ways in which chronic inflammation causes long-term damage.

Casting a deadly NET

As we age, we suffer from the ever-increasing chronic inflammation known as inflammaging. This persistent, smoldering background of low-grade inflammation harms wound healing and promotes multiple age-related diseases. Senescent cells, a weakened immune system, and chronic infections are all proposed to contribute to inflammaging.

New technique shows promise for heart muscle regeneration

Researchers at Duke-NUS Medical School, Singapore, have developed an approach to regenerate heart muscle using stem cells. Their method for priming stem cells to become heart tissues could potentially enable heart regeneration stem cell therapies, according to their study published in the journal Cell Reports.

The self-regeneration of human following injury is extremely limited. Scientists have been studying techniques to prompt different kinds of stem to differentiate into cell precursors, which could then help rebuild heart muscle fibres. However, their approaches have not yet met regulations set forth by the US Food and Drug Administration and the European Medicines Agency for regenerative therapies.

Dr. Lynn Yap, a Senior Research Fellow at Duke-NUS’ Cardiovascular and Metabolic Disorders (CVMD) Programme and the study’s first author, explained, “Regulatory authorities specifically require these stem-cell-derived precursors be prepared from human-only cells and in cultures that use clearly defined chemicals and no animal components. The method must be reproducible, and the cells must have clear characteristics while not leading to adverse side effects when injected.”

Senescent Cell Clearance Improves Intervertebral Disc Degeneration

The presence of senescent cells has been implicated in a wide range of age-related diseases and even conditions such as T1 diabetes. Today, we want to draw your attention to a new publication that explores the relationship between senescent cells and intervertebral disc degeneration (IDD).

It was already known that senescent cells increase during the progression of IDD, but it was not known if they were a driver or a consequence of IDD.

Machines Treating Patients? It’s Already Happening

Today’s efforts in AI are somewhat less flashy, though still potentially revolutionary, and all seem to recognize one vital lesson: treating patients is both art and science. Rather than attempting to replace the physicians in medical practice, AI can, and should, say more experts, become a valuable tool in enhancing what doctors do.


Here’s where AI in medicine excels — and where it doesn’t yet measure up.

/* */